Treatment with interferon for genital HPV in HIV-positive and HIV-negative women.

The administration of interferons can be resorted to, either on its own or in combination with physical destruction methods, when the extent of genital HPV is widespread. Extensive genital HPV involvement is often seen in HIV-positive patients as a consequence of their immunodeficiency. The extension of these lesions may invalidate treatment by physical destruction, while an underlying immunodeficiency renders interferon therapy less efficacious.

[Methoxybutropate in the therapy of PID (pelvic inflammatory diseases)].

A study has been carried out on patients suffering from pelvic inflammatory disease (PID) in chronic form, so as to evaluate the effectiveness of treatment with methoxybutropate (Benflogin-Angelini). The study was carried out on 20 outpatients treated for eight weeks with 300 mg of methoxybutropate three times a day. The results have highlighted the noteworthy effectiveness and high tolerance of methoxybutropate in the treatment of PID.

[Dynamics of the cervical mucosae during hormonal contraception by low-dose estrogens. A controlled prospective clinical study].

The Authors report the results of a prospective clinical study by means of colposcopy, planimetric measurements of iodine-light areas, cytology and target biopsy on 140 women taking low-dosage oral contraceptives and 140 controls. A basal examination and a follow up control at a mean interval of 13 months (min. 6, max.

[Colposcopic evaluation of cervical epithelium during oral contraception. A controlled clinical study].

The Authors report the results of a controlled clinical study by means of colposcopy, cytology and target biopsy on 525 oral contraceptive (O.C.) users and 519 controls.

[Effectiveness of a topical medical treatment following diathermic coagulation: controlled clinical study].

A controlled clinical study has been conducted on the efficacy of a topic therapy. Kanamicine sulphate daily for 6 days and altered to polidesossiribonucleotide for the following 24 days were given after cervical cauterization for ectropion with or without AnTZ. Treated patients were 148 and untreated ones were 155.